133 related articles for article (PubMed ID: 9987656)
1. Selective nuclear morphometry as a prognostic factor of survival in renal cell carcinoma.
Monge JM; Val-Bernal JF; Buelta L; García-Castrillo L; Asensio L
Histol Histopathol; 1999 Jan; 14(1):119-23. PubMed ID: 9987656
[TBL] [Abstract][Full Text] [Related]
2. Nuclear planimetry in renal-cell tumors.
González-Cámpora R; González de Chaves FJ; Mora-Marin J; Rodriguez-González R; Utrilla-Alcolea JC; Rubí-Uría J; Galera-Davidson H
Anal Quant Cytol Histol; 1991 Feb; 13(1):54-60. PubMed ID: 2025374
[TBL] [Abstract][Full Text] [Related]
3. Grading of clear cell renal cell carcinoma should be based on nucleolar prominence.
Delahunt B; Sika-Paotonu D; Bethwaite PB; William Jordan T; Magi-Galluzzi C; Zhou M; Samaratunga H; Srigley JR
Am J Surg Pathol; 2011 Aug; 35(8):1134-9. PubMed ID: 21716085
[TBL] [Abstract][Full Text] [Related]
4. Value of morphometry as an independent prognostic factor in renal cell carcinoma.
Ruiz JL; Hernández M; Martínez J; Vera C; Jimenez-Cruz JF
Eur Urol; 1995; 27(1):54-7. PubMed ID: 7744143
[TBL] [Abstract][Full Text] [Related]
5. Morphometric index of adult renal cell carcinoma. Comparison with the Fuhrman grading system.
Montironi R; Santinelli A; Pomante R; Mazzucchelli R; Colanzi P; Filho AL; Scarpelli M
Virchows Arch; 2000 Jul; 437(1):82-9. PubMed ID: 10963384
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of renal cell carcinoma nuclear grading: multivariate analysis of 333 cases.
Ficarra V; Righetti R; Martignoni G; D'Amico A; Pilloni S; Rubilotta E; Malossini G; Mobilio G
Urol Int; 2001; 67(2):130-4. PubMed ID: 11490206
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of karyometric and clinical characteristics in renal cell carcinoma. Quantitative assessment of tumor heterogeneity.
van der Poel HG; Mulders PF; Oosterhof GO; Schaafsma HE; Hendriks JC; Schalken JA; Debruyne FM
Cancer; 1993 Nov; 72(9):2667-74. PubMed ID: 8402488
[TBL] [Abstract][Full Text] [Related]
8. Volume-weighted mean nuclear volume as a prognostic factor in renal cell carcinoma.
Soda T; Fujikawa K; Ito T; Sasaki M; Nishio Y; Miyakawa M
Lab Invest; 1999 Jul; 79(7):859-67. PubMed ID: 10418826
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.
Petraki CD; Gregorakis AK; Vaslamatzis MM; Papanastasiou PA; Yousef GM; Levesque MA; Diamandis EP
Tumour Biol; 2006; 27(1):1-7. PubMed ID: 16340244
[TBL] [Abstract][Full Text] [Related]
10. Value of morphometric nuclear image analysis using the Feulgen reaction in renal cell carcinoma.
Lee JS; Jung JJ; Lee MC; Park CS; Juhng SW; Oh BR; Moon JD
Anal Quant Cytol Histol; 2000 Feb; 22(1):31-6. PubMed ID: 10696458
[TBL] [Abstract][Full Text] [Related]
11. Computerized nuclear morphometry and survival in renal cell carcinoma: comparison with other prognostic indicators.
Delahunt B; Becker RL; Bethwaite PB; Ribas JL
Pathology; 1994 Oct; 26(4):353-8. PubMed ID: 7892031
[TBL] [Abstract][Full Text] [Related]
12. Fuhrman grading is not appropriate for chromophobe renal cell carcinoma.
Delahunt B; Sika-Paotonu D; Bethwaite PB; McCredie MR; Martignoni G; Eble JN; Jordan TW
Am J Surg Pathol; 2007 Jun; 31(6):957-60. PubMed ID: 17527087
[TBL] [Abstract][Full Text] [Related]
13. Nuclear morphometry accurately predicts recurrence in clinically localized renal cell carcinoma.
Pound CR; Partin AW; Epstein JI; Simons JW; Marshall FF
Urology; 1993 Sep; 42(3):243-8. PubMed ID: 8379023
[TBL] [Abstract][Full Text] [Related]
14. Nuclear morphometry in prognosis of renal adenocarcinoma.
Gutierrez JL; Val-Bernal JF; Garijo MF; Buelta L; Portillo JA
Urology; 1992 Feb; 39(2):130-4. PubMed ID: 1736504
[TBL] [Abstract][Full Text] [Related]
15. Nuclear quantitative grading by discriminant analysis of renal cell carcinoma samples. A patient survival evaluation.
Artacho-Pérula E; Roldán-Villalobos R; Martínez-Cuevas JF; López-Rubio F
J Pathol; 1994 Jun; 173(2):105-14. PubMed ID: 8089804
[TBL] [Abstract][Full Text] [Related]
16. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.
Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV
Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127
[TBL] [Abstract][Full Text] [Related]
17. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma.
Ficarra V; Martignoni G; Maffei N; Brunelli M; Novara G; Zanolla L; Pea M; Artibani W
Cancer; 2005 Jan; 103(1):68-75. PubMed ID: 15573369
[TBL] [Abstract][Full Text] [Related]
18. A comparison between histological grade and nuclear morphometry for predicting the clinical outcome of localized renal cell carcinoma.
Nativ O; Sabo E; Bejar J; Halachmi S; Moskovitz B; Miselevich I
Br J Urol; 1996 Jul; 78(1):33-8. PubMed ID: 8795397
[TBL] [Abstract][Full Text] [Related]
19. A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade.
Paner GP; Amin MB; Alvarado-Cabrero I; Young AN; Stricker HJ; Moch H; Lyles RH
Am J Surg Pathol; 2010 Sep; 34(9):1233-40. PubMed ID: 20679882
[TBL] [Abstract][Full Text] [Related]
20. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
